4.7 Article

Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway

Olfa Khalifa et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a leading chronic liver disease worldwide, and glucagon-like peptide-1 receptor (GLP-1R) agonists can reduce NAFLD by decreasing fatty acid uptake and transport.

SCIENTIFIC REPORTS (2022)

Review Biochemistry & Molecular Biology

Progress in infrared spectroscopy as an efficient tool for predicting protein secondary structure

Shouning Yang et al.

Summary: Infrared spectroscopy is a highly sensitive technique for providing complete information on chemical compositions. It has been widely used to predict protein secondary structures, although the interference of water absorption poses a major challenge for accurate predictions.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Biochemistry & Molecular Biology

Probing the fibrillation of lysozyme by nanoscale-infrared spectroscopy

Zeyaul Islam et al.

Summary: Amyloid fibrillation, related to various neurological disorders, was studied by examining lysozyme fibrillation using nano-infrared spectroscopy (nanoIR). The study showed that lysozyme transformed into mainly parallel beta-sheets in its fibrillar structure, and nanoIR can complement other biophysical studies in analyzing the aggregation process for potential therapeutic design against amyloid disorders.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Review Pharmacology & Pharmacy

A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease

John A. Dougherty et al.

Summary: GLP-1RA and SGLT2 inhibitors have been shown to reduce hepatosteatosis and steatohepatitis in patients with NAFLD and T2DM, while DPP-4 inhibitor therapy was found to be ineffective for patients with hepatosteatosis. Further clinical trials with larger patient populations are recommended to confirm these findings.

ANNALS OF PHARMACOTHERAPY (2021)

Article Medical Laboratory Technology

The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet

Emmanuel Somm et al.

Summary: The study shows that the GLP-1 receptor agonist liraglutide can prevent the accumulation of C16 and C24 ceramides/sphingomyelins species, alleviate inflammation, and inhibit the initiation of fibrosis in the liver of MCD-diet-fed mice. Additionally, liraglutide influences the composition of gut microbiota induced by the MCD-diet.

TRANSLATIONAL RESEARCH (2021)

Article Biochemistry & Molecular Biology

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

Alessandro Mantovani et al.

Summary: Treatment with GLP-1 RAs, particularly liraglutide and semaglutide, shows promising results in reducing liver fat content, serum liver enzyme levels, and improving histological resolution of NASH without worsening liver fibrosis in patients with NAFLD or NASH. Further investigations are warranted.

METABOLITES (2021)

Article Pharmacology & Pharmacy

Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway

Rui Zhou et al.

Summary: Studies indicate that liraglutide may have a beneficial effect in alleviating non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus, potentially more effective than insulin therapy.

FRONTIERS IN PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Rohit Loomba et al.

Summary: NAFLD and NASH are leading chronic liver diseases worldwide, causing progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. These diseases are associated with hepatic glucose and lipid metabolism, and are influenced by genetic, epigenetic, and environmental factors.
Review Medicine, General & Internal

Non-alcoholic fatty liver disease

Elizabeth E. Powell et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a common global health issue with significant associations with metabolic syndrome and type 2 diabetes, leading to serious complications like cirrhosis and hepatocellular carcinoma. While cardiovascular disease and extrahepatic malignancy are the main causes of death in NAFLD patients, advanced liver fibrosis is a key prognostic marker for liver-related outcomes and overall mortality.

LANCET (2021)

Review Environmental Sciences

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors

Oriol Juanola et al.

Summary: NAFLD is a common cause of chronic liver disease in the Western world, often caused by factors such as obesity, metabolic diseases, and environmental agents. Progression from simple hepatic steatosis to NASH can lead to liver cirrhosis and complications. Understanding the mechanisms that cause this progression is crucial for controlling the advancement of the disease.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Endocrinology & Metabolism

Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Tiantian Song et al.

Summary: Liraglutide has shown potential therapeutic efficacy in reducing liver fat, BMI, lipids, and HbA1c in patients with T2DM complicated with NAFLD.

DIABETES THERAPY (2021)

Article Biochemistry & Molecular Biology

Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH

Katharina Luise Hupa-Breier et al.

Summary: The combination therapy of long-acting GLP-1 agonist dulaglutide and SGLT-2 inhibitor empagliflozin has shown significant anti-inflammatory effects in a non-diabetic mouse model of NASH, leading to improved weight loss and glucose homeostasis. These findings suggest potential implications for the treatment of NASH in non-diabetic patients.

BIOMEDICINES (2021)

Article Biochemistry & Molecular Biology

Kaempferol and Kaempferide Attenuate Oleic Acid-Induced Lipid Accumulation and Oxidative Stress in HepG2 Cells

Fangfang Tie et al.

Summary: Kaempferol and kaempferide were found to attenuate lipid accumulation and oxidative stress in HepG2 cells through regulating the expression of lipogenesis-related proteins and adipogenic transcription factors, as well as reducing the expression of heme oxygenase-1. This suggests that these natural compounds may have potential therapeutic benefits for treating NAFLD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, Research & Experimental

Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4

Khaoula Errafii et al.

Summary: This study confirmed that Ex-4 can improve steatosis in HepG2 cells and identified 379 and 180 differentially expressed LncRNAs between untreated, steatotic, and Ex-4-treated steatotic cells. Functional enrichment analysis revealed critical pathways involved in fatty acid and pyruvate metabolism, insulin, PPAR, Wnt, TGF-beta, mTOR, VEGF, NOD-like, and Toll-like receptors signaling pathways.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD

Jingda Li et al.

Summary: Hesperetin, a citrus flavonoid, demonstrates anti-inflammatory effects in NAFLD by activating the PI3 K/AKT-Nrf2 pathway to alleviate oxidative stress, suppress NF-kappa B activation, and reduce inflammatory cytokine secretion. These findings suggest that hesperetin may be an effective dietary supplement for improving NAFLD by targeting both oxidative stress and inflammation pathways.

FOOD & FUNCTION (2021)

Article Endocrinology & Metabolism

Metabolic Messengers: glucagon-like peptide 1

Fiona M. Gribble et al.

Summary: GLP-1, a peptide hormone from the intestinal tract, plays a central role in regulating postprandial glucose homeostasis through insulin secretion, food intake, and gut motility. It serves as the basis for a variety of current drugs for treating type 2 diabetes and obesity, and is also the focus of new drug development.

NATURE METABOLISM (2021)

Article Medicine, Research & Experimental

Exendin-4 inhibits lipotoxicity-induced oxidative stress in β-cells by inhibiting the activation of TLR4/NF-κB signaling pathway

Ximei Shen et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway

Xue Han et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Environmental Sciences

Recovery, physicochemical and functional characteristics of proteins from different meat processing wastewater streams

Cathrine M. S. Bethi et al.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)

Article Chemistry, Multidisciplinary

Peak Fitting Applied to Fourier Transform Infrared and Raman Spectroscopic Analysis of Proteins

Azin Sadat et al.

APPLIED SCIENCES-BASEL (2020)

Review Endocrinology & Metabolism

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease

Laurie L. Baggio et al.

MOLECULAR METABOLISM (2020)

Review Endocrinology & Metabolism

Glucagon-like peptide 1 (GLP-1)

T. D. Mueller et al.

MOLECULAR METABOLISM (2019)

Article Biochemistry & Molecular Biology

Glucagon receptor signaling in metabolic diseases

Nicolai J. Wewer Albrechtsen

PEPTIDES (2018)

Article Chemistry, Multidisciplinary

Rosmarinic acid attenuates hepatic steatosis by modulating ER stress and autophagy in oleic acid-induced HepG2 cells

Govindaraj Jayanthy Balachander et al.

RSC ADVANCES (2018)

Review Endocrinology & Metabolism

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function

Jordan Rowlands et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Article

The Effects of Physical Exercise on Fatty Liver Disease

Dirk J. van der Windt et al.

GENE EXPRESSION (2017)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease: An expanded review

Mark Benedict et al.

WORLD JOURNAL OF HEPATOLOGY (2017)

Article Endocrinology & Metabolism

GLP-1 receptor agonists in NAFLD

J. -M. Petit et al.

DIABETES & METABOLISM (2017)

Review Nutrition & Dietetics

Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease

Christine C. Hsu et al.

ADVANCES IN NUTRITION (2017)

Article Oncology

FTIR microspectroscopy defines early drug resistant human hepatocellular carcinoma (HepG2) cells

Cholpajsorn Junhom et al.

EXPERIMENTAL CELL RESEARCH (2016)

Article Gastroenterology & Hepatology

Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice

Takaya Yamamoto et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Medicine, Research & Experimental

Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease

Mohammad J. Alkhatatbeh et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)

Article Multidisciplinary Sciences

Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling

Mi Hae Seo et al.

PLOS ONE (2016)

Article Biochemistry & Molecular Biology

Protein Quality Control under Oxidative Stress Conditions

Jan-Ulrik Dahl et al.

JOURNAL OF MOLECULAR BIOLOGY (2015)

Article Biochemical Research Methods

Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study

Kanjana Thumanu et al.

JOURNAL OF BIOPHOTONICS (2014)

Article Biochemical Research Methods

Visualization of the biochemical markers of atherosclerotic plaque with the use of Raman, IR and AFM

Katarzyna M. Marzec et al.

JOURNAL OF BIOPHOTONICS (2014)

Article Biochemical Research Methods

Using Fourier transform IR spectroscopy to analyze biological materials

Matthew J. Baker et al.

NATURE PROTOCOLS (2014)

Review Cell Biology

Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action

Jonathan E. Campbell et al.

CELL METABOLISM (2013)

Article Endocrinology & Metabolism

Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways

Ozlem Erdogdu et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)

Article Biochemistry & Molecular Biology

Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy

Jorge Matias Caviglia et al.

JOURNAL OF LIPID RESEARCH (2011)

Article Medicine, General & Internal

Long-Term Persistence of Hormonal Adaptations to Weight Loss

Priya Sumithran et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Biochemistry & Molecular Biology

Fourier transform infrared spectroscopic analysis of protein secondary structures

Jilie Kong et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2007)

Review Biochemistry & Molecular Biology

Applications of ATR-FTIR spectroscopic imaging to biomedical samples

S. G. Kazarian et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)

Review Gastroenterology & Hepatology

Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3

GA Macdonald et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)